Sign In
to Vote &
Create Storyboards.
 
UK scientists have identified how a specific region of a prostate-related protein can be used to trigger the body's immune response against prostate cancer. The study by scientists at Nottingham Trent University - and published in the European Journal of Immunology - could pave the way for new and improved vaccines for prostate cancer. The work focused on the prostatic acid phosphatase (PAP) protein, which is present in more than 90% of prostate tumours.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard